Predictive and prognostic factors for non-small cell lung cancer-potholes in the road to the promised land

Journal of the National Cancer Institute

Volumn 103, Issue 24, 2010, Pages 1810-1811

  Gazdar, Adi F ^a   Schiller, Joan H ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; PEMETREXED;

CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CLINICAL PRACTICE; DNA METHYLATION; EARLY CANCER; EDITORIAL; FOOD AND DRUG ADMINISTRATION; GENE EXPRESSION; GENE MUTATION; HUMAN; LUNG ADENOCARCINOMA; LUNG SQUAMOUS CELL CARCINOMA; MICROARRAY ANALYSIS; ONCOGENE; PREDICTIVE VALUE; PRIORITY JOURNAL; FEMALE; GENE EXPRESSION REGULATION; GENETICS; LUNG NON SMALL CELL CANCER; LUNG TUMOR; MALE; NOTE; PATHOLOGY;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE;

EID: 84856614776     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djr497     Document Type: Editorial

References (8)

1. Chen D-S, Hsu Y-L, Fulp WJ, et al. Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer. J Natl Cancer Inst. 2011;103(24):1859-1870.
2. Pao W, Girard N. New driver mutations in non-small-cell lung cancer. Lancet Oncol. 2011;12(2):175-180.
3. Subramanian J, Simon R. Gene expression-based prognostic signatures in lung cancer: ready for clinical use? J Natl Cancer Inst. 2010;102(7):464-474.
4. Xie Y, Minna JD. Predicting the future for people with lung cancer. Nat Med. 2008;14(8):812-813.
5. Xie Y, Minna JD. Non-small-cell lung cancer mRNA expression signature predicting response to adjuvant chemotherapy. J Clin Oncol. 2010;28(29):4404- 4407.
6. Baggerly KA, Coombes KR. What information should be required to support clinical "omics" publications? Clin Chem. 2011.
7. Baggerly K. Disclose all data in publications. Nature. 2010;467(7314):401.
8. Chen DT, Nasir A, Culhane A, et al. Proliferative genes dominate malignancy-risk gene signature in histologically-normal breast tissue. Breast Cancer Res Treat. 2010;119(2):335-346.